Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LOVE.TO
Strong BuyFull HouseCannara Biotech Inc. · Healthcare · Canada · $141M · Avg Vol: $58K/d
95
StockRankGet insider-trade alerts
Q
70
V
59
M
72
P/E (TTM)
18.1x
ROE
9.7%
D/E
0.3x
Dividend %
—
Loading 1Y...
PRICE (1Y)+7.0%
SMA 50SMA 200
Close
$1.44
RSI (14)
50.0
52W High
$1.50
From 52W High
1.0%
SCORE BREAKDOWN
Quality
70
ROIC
13.9%83.2
ROE
9.7%71.7
GP/Assets
29.6%65.0
Op. Margin
23.1%86.9
FCF/Assets
3.4%62.9
Piotroski
498.0
Int. Cover
7.8x59.7
D/E Ratio
0.29x41.4
Current Ratio
3.00x53.8
Value
59
P/E (TTM)
18.1x62.4
EV/EBITDA
8.6x74.2
P/FCF
34.2x39.1
P/B
1.6x70.5
P/S
1.7x72.2
Div Yield
—N/A
Momentum
72
52W High %
96%94.9
RS 6M
-4%60.0
SMA 50/200
1.05x70.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+85%69.4
Q Growth
17%53.8
FUNDAMENTALS
Market Cap
$141M
P/E (Forward)
9.8x
Gross Margin
42.6%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LOVE.TO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LOVE.TO | Cannara Biotech Inc.(you) | $141M | 95 | Strong Buy |
| RX.V | BioSyent Inc. | $130M | 91 | Strong Buy |
| MDP.TO | Medexus Pharmaceuticals Inc. | $118M | 89 | Strong Buy |
| XLY.TO | Auxly Cannabis Group Inc. | $232M | 98 | Strong Buy |
| CPH.TO | Cipher Pharmaceuticals Inc. | $265M | 92 | Strong Buy |
| OGI.TO | Organigram Global Inc. | $171M | 66 | Buy |
| HLS.TO | HLS Therapeutics Inc. | $80M | 66 | Buy |
| TSND.TO | TerrAscend Corp. | $243M | 60 | Hold |
| DB.V | Decibel Cannabis Company Inc. | $51M | 67 | Buy |
| GUD.TO | Knight Therapeutics Inc. | $682M | 76 | Buy |
Peer medians: ROE -37.9% · P/E 17.2x · Gross margin 45.1%